{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+furoate+50mcg", "query": { "intervention": "Fluticasone furoate 50mcg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 44, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+furoate+50mcg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-27T13:12:06.203Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00102765", "title": "Study Of Asthma In Patients Of African Descent", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol powder", "type": "DRUG" }, { "name": "fluticasone propionate powder", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 479, "start_date": "2004-11", "completion_date": "2007-04", "has_results": false, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-09-27T13:12:06.203Z", "location_count": 75, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 61 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00102765" }, { "nct_id": "NCT00984659", "title": "Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone propionate/salmeterol combination product", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 366, "start_date": "2009-10-29", "completion_date": "2010-07-01", "has_results": true, "last_update_posted_date": "2018-08-29", "last_synced_at": "2026-09-27T13:12:06.203Z", "location_count": 39, "location_summary": "Jasper, Alabama • Mobile, Alabama • Los Angeles, California + 35 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00984659" }, { "nct_id": "NCT00568347", "title": "Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COPD" ], "interventions": [ { "name": "fluticasone 100mcg/ salmeterol 50mcg", "type": "DRUG" }, { "name": "fluticasone 250/salmeterol 50", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "salmeterol and fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arthur F Gelb MD", "sponsor_class": "INDIV", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "20 Years to 85 Years" }, "enrollment_count": 39, "start_date": "2006-01", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2015-03-17", "last_synced_at": "2026-09-27T13:12:06.203Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00568347" }, { "nct_id": "NCT01017952", "title": "A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF/GW642444 Inhalation Powder", "type": "DRUG" }, { "name": "GW642444 Inhalation Powder", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1635, "start_date": "2009-09-25", "completion_date": "2011-10-17", "has_results": true, "last_update_posted_date": "2018-08-31", "last_synced_at": "2026-09-27T13:12:06.203Z", "location_count": 89, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Ozark, Alabama + 79 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Ozark", "state": "Alabama" }, { "city": "Tallassee", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01017952" }, { "nct_id": "NCT00441441", "title": "A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "fluticasone propionate/salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 351, "start_date": "2007-02", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-09-27T13:12:06.203Z", "location_count": 20, "location_summary": "Huntington Beach, California • Long Beach, California • Riverside, California + 16 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00441441" }, { "nct_id": "NCT01563029", "title": "A Dose-ranging Study of Fluticasone Furoate (FF)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Furoate", "type": "DRUG" }, { "name": "Fluticasone Propionate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "5 Years to 11 Years" }, "enrollment_count": 597, "start_date": "2012-03-28", "completion_date": "2014-09-24", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-09-27T13:12:06.203Z", "location_count": 37, "location_summary": "Little Rock, Arkansas • Costa Mesa, California • Huntington Beach, California + 33 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01563029" }, { "nct_id": "NCT01072149", "title": "A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Furoate (FF)/GW642444 Inhalation Powder", "type": "DRUG" }, { "name": "placebo", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 54, "start_date": "2010-01-01", "completion_date": "2010-07-01", "has_results": true, "last_update_posted_date": "2017-11-09", "last_synced_at": "2026-09-27T13:12:06.203Z", "location_count": 8, "location_summary": "DeLand, Florida • Orlando, Florida • Madisonville, Kentucky + 5 more", "locations": [ { "city": "DeLand", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Madisonville", "state": "Kentucky" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Greenville", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01072149" }, { "nct_id": "NCT00784550", "title": "A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Tiotropium Bromide", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "40 Years to 99 Years" }, "enrollment_count": 342, "start_date": "2008-12", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2016-11-23", "last_synced_at": "2026-09-27T13:12:06.203Z", "location_count": 35, "location_summary": "Riverside, California • Fort Collins, Colorado • Clearwater, Florida + 31 more", "locations": [ { "city": "Riverside", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeLand", "state": "Florida" }, { "city": "Naranja", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00784550" }, { "nct_id": "NCT01110200", "title": "Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "ADVAIR DISKUS 250/50 mg BID", "type": "DRUG" }, { "name": "SEREVENT 50 mcg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 639, "start_date": "2010-04-30", "completion_date": "2012-05-08", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-09-27T13:12:06.203Z", "location_count": 74, "location_summary": "Birmingham, Alabama • Florence, Alabama • Mobile, Alabama + 66 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110200" }, { "nct_id": "NCT00358358", "title": "Chronic Obstructive Pulmonary Disease Endpoints Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Propionate/Salmeterol 500/50mcg combination", "type": "DRUG" }, { "name": "Fluticasone Propionate 500mcg", "type": "DRUG" }, { "name": "Salmeterol 50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 163, "start_date": "2006-03", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2017-01-20", "last_synced_at": "2026-09-27T13:12:06.203Z", "location_count": 4, "location_summary": "Absecon, New Jersey • Charleston, South Carolina • Greenville, South Carolina + 1 more", "locations": [ { "city": "Absecon", "state": "New Jersey" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Greenville", "state": "South Carolina" }, { "city": "Spartanburg", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00358358" } ] }